Investing.com — US stock futures steadied Tuesday, with investors reluctant to chase the market too much higher after Donald Trump’s threatened a global trade war once he gets into office.
Here are some of the biggest premarket US stock movers today:
-
Kohl’s (NYSE:KSS) stock slumped 12% after the retailer cut its annual sales forecast for the third time this year, in a sign the department-store chain is struggling to draw in shoppers ahead of a deal-heavy holiday shopping season.
-
Best Buy (NYSE:BBY) stock fell 7.4% after the electronics retailer cut its full-year sales forecast as it missed quarterly revenue expectations due to softer demand.
-
Dick’s Sporting Goods (NYSE:DKS) stock rose 6.4% after the retailer raised its full-year guidance after what CEO Lauren Hobart called an "excellent" back-to-school shopping season and better-than-expected comparable sales for its third quarter.
-
Ford (NYSE:F) stock fell 1.8% and General Motors (NYSE:GM) stock dropped 3.8% as investors shunned the auto giants in the wake of Trump’s tariff comments as they have highly integrated supply chains across Mexico, the US and Canada.
-
Novo Nordisk (NYSE:NVO) stock rose 2.2%, with the weight-loss drug maker benefitting from President Joe Biden proposing expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid.
-
Burlington Stores (NYSE:BURL) stock fell 5.4% after the department store retailer’s fourth-quarter forecast for earnings and comparable sales growth missed expectations.
-
Rumble (NASDAQ:RUM) stock rose 3% after the video platform said it will begin allocating a portion of its excess cash reserves to bitcoin, making purchases of up to $20 million in the cryptocurrency.
-
Intel (NASDAQ:INTC) stock rose 1.2% after the US Commerce Department said it was finalizing a $7.86 billion government subsidy for the tech giant, down from the $8.5 billion announced in March after the California-based chips maker won a separate $3 billion award from the Pentagon.
-
Poseida Therapeutics (NASDAQ:PSTX) stock soared over 200% after Switzerland's Roche said it will acquire the cell therapy maker in a cash deal worth up to $1.5 billion.
-
Analog Devices (NASDAQ:ADI) stock rose 5.6% after the semiconductor reported a profit for the fourth quarter that decreased from the same period last year but beat the Street estimates.
Comments (0)